FIELD: medicine.
SUBSTANCE: invention concerns pharmaceutical composition resulted from sublimation drying in vacuum, containing oxalyplatine as an active component and pharmaceutically acceptable carrier containing as a carrier at least one alcoholic sugar of not-animal origin, thus mass ratio of oxalyplatine to alcoholic sugar of not-animal origin makes 1:3 to 1:7.
EFFECT: invention provides decreased risk of virus infection, especially animal cancellous encephalopathy agent.
5 cl, 4 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING LYOPHILISED ANTIVIRAL AGENT | 2010 |
|
RU2454221C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | 2012 |
|
RU2520346C2 |
| TECHNIQUE OF PRODUCTION OF LYOPHILIZATE | 0 |
|
SU1836079A3 |
| EPOPROSTENOL-CONTAINING COMPOSITION AND METHOD OF ITS OBTAINING | 2007 |
|
RU2423130C2 |
| PHARMACEUTICAL COMPOSITION FOR PARENTERAL DELIVERY IN FORM OF LYOPHILIZATE AND METHOD OF ITS OBTAINING | 2007 |
|
RU2370258C2 |
| STRAIN OF HISTOPHILUS SOMNI BACTERIA INTENDED FOR PRODUCTION OF MONO- AND POLYVALENT IMMUNOGENIC COMPOSITIONS AIMED AT SPECIFIC PREVENTION OF HISTOPHILOSIS (HERD INFERTILITY) IN CATTLE | 2020 |
|
RU2754005C1 |
| METHOD FOR PRODUCING A PHARMACEUTICAL FORMULATION OF ROCURONIUM BROMIDE IN THE FORM OF A STABLE LYOPHILISATE AND PHARMACEUTICAL COMPOSITION OBTAINED USING SAID METHOD | 2013 |
|
RU2594062C2 |
| METHOD FOR PREPARING INJECTION MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304430C2 |
| PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM | 2017 |
|
RU2678203C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-ISCHEMIC AND ANTIOXIDANT ACTIVITY AND METHOD FOR PREPARING IT | 2013 |
|
RU2545833C1 |
